Sign in
RGBPP Stock Price, Chart, Stats & News
Regen BioPharma, Inc.
Save
Regen BioPharma, Inc. (RGBPP) does not currently pay a dividend.
208,174
Market cap
–
Current P/E
–
Forward P/E
RGBPP chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Regen BioPharma, Inc. is dedicated to advancing regenerative medicine solutions across the United States. The company's scientific endeavors involve identifying small molecules that modulate NR2F6, with the aim of either stimulating immune cells for cancer treatments or suppressing them for managing autoimmune conditions. Currently, its product pipeline and therapeutic approaches are in nascent developmental phases.
Similar securities
Based on sector and market capitalization
Report issue